Response to Kozek et al.
暂无分享，去创建一个
[1] D. Troost,et al. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain , 2005, Pain.
[2] H. Kress,et al. Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. , 2005, British journal of anaesthesia.
[3] T. Yaksh,et al. The Use of Intrathecal Midazolam in Humans: A Case Study of Process , 2004, Anesthesia and analgesia.
[4] J. Kal,et al. Treatment of neuropathic cancer pain with continuous intrathecal administration of S (+)‐ketamine , 2004, Acta anaesthesiologica Scandinavica.
[5] T. Yaksh,et al. Epidural ketamine in healthy children--what's the point? , 2003, Anesthesia and analgesia.
[6] H. Kress,et al. The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. , 2001, Anesthesia and analgesia.
[7] J. Lange,et al. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/ bupivacaine mixture in cancer pain patients , 1997, Acta anaesthesiologica Scandinavica.
[8] C. Nordborg,et al. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. , 1992, Anesthesiology.